Traders Rush To Buy Biotech Following Q1 Earnings Beat
07 Maio 2024 - 12:55PM
AllPennyStocks.com
A California-based biotech company is stealing
the show so far during Tuesday’s session after the company reported
Q1 2024 earnings after yesterday’s market...
To read the full story on AllPennyStocks.com, click
here.
FibroGen (NASDAQ:FGEN)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
FibroGen (NASDAQ:FGEN)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
